These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 834114

  • 21. Proline and hepatic lipogenesis.
    Sugden MC, Watts DI, West PS, Palmer TN.
    Biochim Biophys Acta; 1984 Apr 24; 798(3):368-73. PubMed ID: 6712996
    [Abstract] [Full Text] [Related]

  • 22. The role of ATP citrate-lyase in the metabolic regulation of plasma lipids. Hypolipidaemic effects of SB-204990, a lactone prodrug of the potent ATP citrate-lyase inhibitor SB-201076.
    Pearce NJ, Yates JW, Berkhout TA, Jackson B, Tew D, Boyd H, Camilleri P, Sweeney P, Gribble AD, Shaw A, Groot PH.
    Biochem J; 1998 Aug 15; 334 ( Pt 1)(Pt 1):113-9. PubMed ID: 9693110
    [Abstract] [Full Text] [Related]

  • 23. Lipid lowering effect of S-methyl cysteine sulfoxide from Allium cepa Linn in high cholesterol diet fed rats.
    Kumari K, Augusti KT.
    J Ethnopharmacol; 2007 Feb 12; 109(3):367-71. PubMed ID: 16987625
    [Abstract] [Full Text] [Related]

  • 24. Central and Peripheral Glucagon Reduces Hyperlipidemia in Rats and Hamsters.
    Patel V, Joharapurkar A, Kshirsagar S, Patel HM, Pandey D, Patel D, Shah K, Bahekar R, Shah GB, Jain MR.
    Drug Res (Stuttg); 2017 Jun 12; 67(6):318-326. PubMed ID: 28445900
    [Abstract] [Full Text] [Related]

  • 25. Hydroxycitrate delays early mortality in mice and promotes muscle regeneration while inducing a rich hepatic energetic status.
    Espadas I, Cáliz-Molina MÁ, López-Fernández-Sobrino R, Panadero-Morón C, Sola-García A, Soriano-Navarro M, Martínez-Force E, Venegas-Calerón M, Salas JJ, Martín F, Gauthier BR, Alfaro-Cervelló C, Martí-Aguado D, Capilla-González V, Martín-Montalvo A.
    Aging Cell; 2024 Sep 12; 23(9):e14205. PubMed ID: 38760909
    [Abstract] [Full Text] [Related]

  • 26. Vitamin A induced hypertriglyceridemia in cholesterol-fed rats.
    Solomon LW, Erdman JW.
    Lipids; 1980 Mar 12; 15(3):157-62. PubMed ID: 7374366
    [Abstract] [Full Text] [Related]

  • 27. Hypolipidemic activity of Achyranthus aspera Linn in normal and triton induced hyperlipemic rats.
    Khanna AK, Chander R, Singh C, Srivastava AK, Kapoor NK.
    Indian J Exp Biol; 1992 Feb 12; 30(2):128-30. PubMed ID: 1521862
    [Abstract] [Full Text] [Related]

  • 28. Arterial lipid biochemistry in the spontaneously hyperlipidemic Zucker rat and its similarity to early atherogenesis.
    St John LC, Bell FP.
    Atherosclerosis; 1991 Feb 12; 86(2-3):139-44. PubMed ID: 1872908
    [Abstract] [Full Text] [Related]

  • 29. Atorvastatin treatment induced peroxisome proliferator-activated receptor alpha expression and decreased plasma nonesterified fatty acids and liver triglyceride in fructose-fed rats.
    Roglans N, Sanguino E, Peris C, Alegret M, Vázquez M, Adzet T, Díaz C, Hernández G, Laguna JC, Sánchez RM.
    J Pharmacol Exp Ther; 2002 Jul 12; 302(1):232-9. PubMed ID: 12065722
    [Abstract] [Full Text] [Related]

  • 30. Reduction of hyperlipidemia in the LA/N-corpulent rat by dietary fish oil containing n-3 fatty acids.
    Dolphin PJ, Amy RM, Koeslag DG, Limoges BF, Russell JC.
    Biochim Biophys Acta; 1988 Oct 14; 962(3):317-29. PubMed ID: 3167083
    [Abstract] [Full Text] [Related]

  • 31. Brown-adipose-tissue lipogenesis in starvation: effects of insulin and (-) hydroxycitrate.
    Sugden MC, Watts DI, Marshall CE, McCormack JG.
    Biosci Rep; 1982 May 14; 2(5):289-97. PubMed ID: 7046828
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal models.
    Krause BR, Newton RS.
    Atherosclerosis; 1995 Oct 14; 117(2):237-44. PubMed ID: 8801869
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Green tea polyphenols ameliorate non-alcoholic fatty liver disease through upregulating AMPK activation in high fat fed Zucker fatty rats.
    Tan Y, Kim J, Cheng J, Ong M, Lao WG, Jin XL, Lin YG, Xiao L, Zhu XQ, Qu XQ.
    World J Gastroenterol; 2017 Jun 07; 23(21):3805-3814. PubMed ID: 28638220
    [Abstract] [Full Text] [Related]

  • 37. Effects of insulin and glucagon on fatty acid synthesis from acetate by hepatocytes incubated with (--)-hydroxycitrate.
    Beynen AC, Geelen MJ.
    Endokrinologie; 1982 Jun 07; 79(2):308-10. PubMed ID: 6751811
    [Abstract] [Full Text] [Related]

  • 38. Effect of (-)hydroxycitrate on the activities of ATP citrate lyase and the enzymes of acetyl-CoA metabolism in rat brain.
    Szutowicz A, Stepień M, Lysiak W, Angielski S.
    Acta Biochim Pol; 1976 Jun 07; 23(2-3):227-34. PubMed ID: 970036
    [Abstract] [Full Text] [Related]

  • 39. YM-53601, a novel squalene synthase inhibitor, suppresses lipogenic biosynthesis and lipid secretion in rodents.
    Ugawa T, Kakuta H, Moritani H, Inagaki O, Shikama H.
    Br J Pharmacol; 2003 May 07; 139(1):140-6. PubMed ID: 12746232
    [Abstract] [Full Text] [Related]

  • 40. Pu-erh tea, green tea, and black tea suppresses hyperlipidemia, hyperleptinemia and fatty acid synthase through activating AMPK in rats fed a high-fructose diet.
    Huang HC, Lin JK.
    Food Funct; 2012 Feb 07; 3(2):170-7. PubMed ID: 22127373
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.